Skip to main content
. 2018 Oct 18;22(12):6368–6379. doi: 10.1111/jcmm.13963

Figure 2.

Figure 2

RT‐PCR A, and immunostaining. B, C, analysis of ERα and ERβ expression in prolactinomas from bromocriptine‐sensitive and ‐resistant patients. (Student's t test, ns, non‐significant, *< 0.05)